// App-Quantinova.ai

P4-275 : A NOVEL CSF 16PLEX NEURODEGENERATION ASSAY

Researchers

Presenter

  • Christopher Loener

Principal Investigators

  • Malcolm Andrew Ward

  • Henrik Zetterberg

  • Johan Gobom

  • Kaj Blennow

  • Ian Pike

Medical Centers

  • Proteome Sciences, Frankfurt a. M., Germany.

  • Institution of Neuroscience and Physiology, Moelndal, Sweden

  • Proteome Sciences plc, Cobham, United Kingdom

  • Proteome Sciences, London, United Kingdom

  • Sahlgrenska academy at University of Gothenburg, Gothenburg, Sweden

Locations

  • Germany

  • United Kingdom

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Alpha-2-macroglobulin

  • Apolipoprotein E

  • Chromogranin A

  • Clusterin

  • Cystatin C

  • Fibrinogen

  • Cerebrospinal fluid

Drug/Treatment

  • Fibrinogen (IV)

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final